Do analysts prefer SSKN or AMIX?

Autonomix Medical has a consensus price target of $2.00, indicating a potential upside of 428.40%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Strata Skin Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer SSKN or AMIX?

In the previous week, Autonomix Medical had 6 more articles in the media than Strata Skin Sciences. MarketBeat recorded 7 mentions for Autonomix Medical and 1 mentions for Strata Skin Sciences. Autonomix Medical's average media sentiment score of 0.54 beat Strata Skin Sciences' score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Strata Skin Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Autonomix Medical 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer SSKN or VBIO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Valion Bio, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate IVF or SSKN?

INVO Fertility presently has a consensus price target of $20.00, suggesting a potential upside of 1,318.44%. Given INVO Fertility's stronger consensus rating and higher probable upside, research analysts clearly believe INVO Fertility is more favorable than Strata Skin Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate SSKN or BBLG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate SSKN or LYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lyra Therapeutics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Strata Skin Sciences (SSKN) Competitors

$0.13 +0.01 (+8.26%)

As of 06/10/2026 11:41 AM Eastern

Compare

SSKN vs. AMIX, VBIO, IVF, BBLG, and LYRA

Should you buy Strata Skin Sciences stock or one of its competitors? MarketBeat compares Strata Skin Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Strata Skin Sciences include Autonomix Medical (AMIX), Valion Bio, Inc. Common Stock (VBIO), INVO Fertility (IVF), Bone Biologics (BBLG), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry.

How does Strata Skin Sciences compare to Autonomix Medical?

Strata Skin Sciences (NASDAQ:SSKN) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

Autonomix Medical has a consensus price target of $2.00, indicating a potential upside of 428.40%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by company insiders. Comparatively, 6.2% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Strata Skin Sciences has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98M	0.02	-$10.09M	-$1.41	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A

Strata Skin Sciences has a beta of -0.06, meaning that its share price is 106% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.43, meaning that its share price is 243% less volatile than the broader market.

In the previous week, Autonomix Medical had 6 more articles in the media than Strata Skin Sciences. MarketBeat recorded 7 mentions for Autonomix Medical and 1 mentions for Strata Skin Sciences. Autonomix Medical's average media sentiment score of 0.54 beat Strata Skin Sciences' score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Strata Skin Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Autonomix Medical	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Autonomix Medical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Autonomix Medical's return on equity of -239.36% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
Autonomix Medical	N/A	-239.36%	-192.46%

Summary

Strata Skin Sciences beats Autonomix Medical on 8 of the 15 factors compared between the two stocks.

How does Strata Skin Sciences compare to Valion Bio, Inc. Common Stock?

Strata Skin Sciences (NASDAQ:SSKN) and Valion Bio, Inc. Common Stock (NASDAQ:VBIO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Valion Bio, Inc. Common Stock has lower revenue, but higher earnings than Strata Skin Sciences. Valion Bio, Inc. Common Stock is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98M	0.02	-$10.09M	-$1.41	N/A
Valion Bio, Inc. Common Stock	$780K	3.27	-$8.88M	-$6.68	N/A

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 4.3% of Valion Bio, Inc. Common Stock shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by company insiders. Comparatively, 14.5% of Valion Bio, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Strata Skin Sciences and Strata Skin Sciences both had 1 articles in the media. Valion Bio, Inc. Common Stock's average media sentiment score of 1.87 beat Strata Skin Sciences' score of 0.00 indicating that Valion Bio, Inc. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
Strata Skin Sciences	Neutral
Valion Bio, Inc. Common Stock	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Valion Bio, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Valion Bio, Inc. Common Stock has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Valion Bio, Inc. Common Stock's return on equity of -138.10% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
Valion Bio, Inc. Common Stock	N/A	-138.10%	-63.67%

Strata Skin Sciences has a beta of -0.06, meaning that its stock price is 106% less volatile than the broader market. Comparatively, Valion Bio, Inc. Common Stock has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market.

Summary

Strata Skin Sciences and Valion Bio, Inc. Common Stock tied by winning 6 of the 12 factors compared between the two stocks.

How does Strata Skin Sciences compare to INVO Fertility?

INVO Fertility (NASDAQ:IVF) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Strata Skin Sciences has a net margin of -35.64% compared to INVO Fertility's net margin of -367.34%. INVO Fertility's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-367.34%	N/A	-23.68%
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

INVO Fertility has a beta of 2.33, suggesting that its share price is 133% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market.

INVO Fertility presently has a consensus price target of $20.00, suggesting a potential upside of 1,318.44%. Given INVO Fertility's stronger consensus rating and higher probable upside, research analysts clearly believe INVO Fertility is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Strata Skin Sciences has higher revenue and earnings than INVO Fertility. Strata Skin Sciences is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.84M	0.37	-$25.13M	-$3.15 thousand	N/A
Strata Skin Sciences	$30.98M	0.02	-$10.09M	-$1.41	N/A

In the previous week, INVO Fertility and INVO Fertility both had 1 articles in the media. INVO Fertility's average media sentiment score of 1.87 beat Strata Skin Sciences' score of 0.00 indicating that INVO Fertility is being referred to more favorably in the media.

Company	Overall Sentiment
INVO Fertility	Very Positive
Strata Skin Sciences	Neutral

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 0.7% of INVO Fertility shares are held by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

INVO Fertility beats Strata Skin Sciences on 9 of the 15 factors compared between the two stocks.

How does Strata Skin Sciences compare to Bone Biologics?

Strata Skin Sciences (NASDAQ:SSKN) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 34.3% of Bone Biologics shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 6.1% of Bone Biologics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Bone Biologics had 1 more articles in the media than Strata Skin Sciences. MarketBeat recorded 2 mentions for Bone Biologics and 1 mentions for Strata Skin Sciences. Bone Biologics' average media sentiment score of 0.43 beat Strata Skin Sciences' score of 0.00 indicating that Bone Biologics is being referred to more favorably in the news media.

Company	Overall Sentiment
Strata Skin Sciences	Neutral
Bone Biologics	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bone Biologics has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Bone Biologics' return on equity of -50.47% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
Bone Biologics	N/A	-50.47%	-47.40%

Strata Skin Sciences has a beta of -0.06, meaning that its share price is 106% less volatile than the broader market. Comparatively, Bone Biologics has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

Bone Biologics has lower revenue, but higher earnings than Strata Skin Sciences. Bone Biologics is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98M	0.02	-$10.09M	-$1.41	N/A
Bone Biologics	N/A	N/A	-$3.11M	-$2.27	N/A

Summary

Bone Biologics beats Strata Skin Sciences on 7 of the 12 factors compared between the two stocks.

How does Strata Skin Sciences compare to Lyra Therapeutics?

Strata Skin Sciences (NASDAQ:SSKN) and Lyra Therapeutics (NASDAQ:LYRA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

Strata Skin Sciences has a beta of -0.06, meaning that its share price is 106% less volatile than the broader market. Comparatively, Lyra Therapeutics has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market.

Strata Skin Sciences has higher revenue and earnings than Lyra Therapeutics. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Lyra Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98M	0.02	-$10.09M	-$1.41	N/A
Lyra Therapeutics	$600K	1.78	-$93.43M	-$19.15	N/A

In the previous week, Strata Skin Sciences had 1 more articles in the media than Lyra Therapeutics. MarketBeat recorded 1 mentions for Strata Skin Sciences and 0 mentions for Lyra Therapeutics. Strata Skin Sciences' average media sentiment score of 0.00 equaled Lyra Therapeutics'average media sentiment score.

Company	Overall Sentiment
Strata Skin Sciences	Neutral
Lyra Therapeutics	Neutral

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 95.6% of Lyra Therapeutics shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 3.3% of Lyra Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Strata Skin Sciences has a net margin of -35.64% compared to Lyra Therapeutics' net margin of -5,491.17%. Strata Skin Sciences' return on equity of -476.73% beat Lyra Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
Lyra Therapeutics	-5,491.17%	-1,010.91%	-58.92%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lyra Therapeutics	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Strata Skin Sciences beats Lyra Therapeutics on 8 of the 13 factors compared between the two stocks.

Get Strata Skin Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SSKN vs. The Competition

Export

Metric	Strata Skin Sciences	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$771K	$1.54B	$6.50B	$11.95B
Dividend Yield	N/A	N/A	2.67%	5.61%
P/E Ratio	-0.05	77.43	24.41	23.63
Price / Sales	0.02	6.82	502.24	103.14
Price / Cash	N/A	23.11	43.05	54.72
Price / Book	0.11	4.84	10.43	6.70
Net Income	-$10.09M	-$54.76M	$3.56B	$337.26M
7 Day Performance	-12.08%	-6.80%	-2.94%	-2.43%
1 Month Performance	1.79%	2.62%	-0.39%	0.19%
1 Year Performance	-94.25%	-11.32%	20.10%	23.15%

Strata Skin Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SSKN Strata Skin Sciences	0.1169 of 5 stars	$0.13 +8.3%	N/A	-94.4%	$771K	$30.98M	N/A	120	News Coverage
AMIX Autonomix Medical	2.5709 of 5 stars	$0.40 +0.6%	$2.00 +394.2%	-74.9%	$2.78M	N/A	N/A	1	News Coverage Short Interest Increase
VBIO Valion Bio, Inc. Common Stock	1.9431 of 5 stars	$0.74 -3.3%	N/A	-79.6%	$2.45M	$780K	N/A	10	Positive News Gap Down
IVF INVO Fertility	3.0709 of 5 stars	$1.40 +7.7%	$20.00 +1,328.6%	-99.2%	$2.32M	$6.84M	N/A	10	Positive News Gap Up
BBLG Bone Biologics	0.8064 of 5 stars	$1.23 -1.6%	N/A	-77.7%	$2.24M	N/A	N/A	2	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SSKN) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Strata Skin Sciences (SSKN) Competitors

SSKN vs. AMIX, VBIO, IVF, BBLG, and LYRA

How does Strata Skin Sciences compare to Autonomix Medical?

Summary

How does Strata Skin Sciences compare to Valion Bio, Inc. Common Stock?

Summary

How does Strata Skin Sciences compare to INVO Fertility?

Summary

How does Strata Skin Sciences compare to Bone Biologics?

Summary

How does Strata Skin Sciences compare to Lyra Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSKN vs. The Competition

Strata Skin Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Strata Skin Sciences (SSKN) Competitors

SSKN vs. AMIX, VBIO, IVF, BBLG, and LYRA

How does Strata Skin Sciences compare to Autonomix Medical?

Do analysts prefer SSKN or AMIX?

Do insiders & institutionals have more ownership in SSKN or AMIX?

Which has stronger earnings & valuation, SSKN or AMIX?

Which has more risk and volatility, SSKN or AMIX?

Does the media prefer SSKN or AMIX?

Is SSKN or AMIX more profitable?

Summary

How does Strata Skin Sciences compare to Valion Bio, Inc. Common Stock?

Which has better valuation & earnings, SSKN or VBIO?

Do insiders and institutionals have more ownership in SSKN or VBIO?

Does the media prefer SSKN or VBIO?

Do analysts prefer SSKN or VBIO?

Is SSKN or VBIO more profitable?

Which has more volatility and risk, SSKN or VBIO?

Summary

How does Strata Skin Sciences compare to INVO Fertility?

Is IVF or SSKN more profitable?

Which has more risk & volatility, IVF or SSKN?

Do analysts rate IVF or SSKN?

Which has stronger valuation and earnings, IVF or SSKN?

Does the media refer more to IVF or SSKN?

Do institutionals & insiders have more ownership in IVF or SSKN?

Summary

How does Strata Skin Sciences compare to Bone Biologics?

Do insiders & institutionals hold more shares of SSKN or BBLG?

Does the media prefer SSKN or BBLG?

Do analysts rate SSKN or BBLG?

Is SSKN or BBLG more profitable?

Which has more volatility & risk, SSKN or BBLG?

Which has preferable valuation & earnings, SSKN or BBLG?

Summary

How does Strata Skin Sciences compare to Lyra Therapeutics?

Which has more volatility and risk, SSKN or LYRA?

Which has stronger earnings and valuation, SSKN or LYRA?

Does the media favor SSKN or LYRA?

Do insiders and institutionals hold more shares of SSKN or LYRA?

Is SSKN or LYRA more profitable?

Do analysts rate SSKN or LYRA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSKN vs. The Competition

Strata Skin Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools